The new generation of FREMS
1 / 12Pages

IC IABET THY D UROPA NE D IA B E T IC FOOT Electroceuticals for the treatment of neurovascular diseases

OUR MISSION: TO GUARANTEE RESULTS TO IMPROVE QUALITY OF LIFE Fremslife originates from the innovation of Electroceuticals, also known as Bioelectronic Medicine, which uses electrical stimulation to influence and change bodily functions. Fremslife has developed an innovative and integrated solution for the treatment and reduction of pain in neurovascular diseases, based on Electroceuticals-oriented therapeutic and diagnostic programmes. The heart of the Fremslife technology is Frems™ (Frequency Rhythmic Electrical Modulation System). Frems™ is a technology covered by more than 10...

THE EFFICACY OF A THERAPEUTIC SOLUTION CAN ONLY BE ESTABLISHED BY ANALYSING ITS RESULTS With the scientific evidence provided by over 100 national and international publications, we have demonstrated that the results obtained with our Frems™ technology make it an efficacious option for the treatment of many vascular disorders. Every day, around the world, more than 10,000 patients are treated with our exclusive technology to provide pain relief and manage conditions such as: • painful diabetic neuropathy • diabetic foot • chronic sores • claud

WHAT IS ELECTROCEUTICALS It is a new discipline that includes bioelectric medicine, i.e. the use of electrical stimulation of nerve cells to influence and modify physiological mechanisms. The Frems™ technology belongs to this area of medicine as it has been demonstrated, by means of scientific and clinical studies, that it interacts with the human body by influencing certain basic mechanisms such as vasomotion and the H-reflex. “Le Scienze”, May 2015, n. 561, Gruppo Editoriale L’Espresso THE SCIENTIFIC BASES OF THE FREMS™ TECHNOLOGY Cells exchange information by means of a complex...

HOW DOES FREMS™ WORK Frems™ (Frequency Rhythmic Electrical Modulation System), is constituted by trains of sequences of electric impulses (such as spikes), characterised by a minimal quantity of charge, whose frequency and duration can be varied according to pre-set regimens. The amplitude of the impulse is set by the operator using a remote control, according to the patient’s sensitivity threshold and the tissue stimulated. Subsequently, the system modulates maximum amplitude according to the ion balance of the tissue underneath the electrodes, to keep it constantly balanced (Biofeedback)....

APTIVA 4 NOW THE BEST IS EVEN BETTER New more powerful hardware New more user-friendly, faster-working software New user interface New protocols with automations that make application simpler and faster Continuous treatment efficacy monitoring system Elegant, light and easy to transport

VASCULAR APPLICATIONS FREMS™ EXERTS THE FOLLOWING SPECIFIC EFFECTS Vasomotor action Vasomotion is the rhythmic pulsing activity of the smooth muscle of the vessels that regulates microcirculation activity. The changes in the microcirculation’s perfusion velocity during Frems™, measured by Doppler flow laser, demonstrate the presence of induced vasomotor activity. oxygen and nutritional factors. In the case of diabetic patients with microangiopathies suffering from vessel endothelium inflammation, therefore with high circulating TNF- and IL-2 values, it has been seen to significantly reduce...

THE CONDITIONS TREATED WITH FREMS™ PAINFUL DIABETIC NEUROPATHY CHRONIC SKIN SORES OF VARIOUS ORIGINS ∙ Increase in sensory and tactile perception ∙ Early management of pain symptoms ∙ Increase in motor nerve conduction velocity ∙ Effects lasting up to 4 months PERIPHERAL ARTERIAL DISEASE ∙ Increase in oxymetry values ∙ Improvement in the parameters that are characteristic of the endothelial system ∙ Recovery of perilesional skin perfusion and promotion of e

HOW IS FREMS™ APPLIED Frems™ consists in applying an electric signal that is transmitted by transcutaneous electrodes. These electrodes are dedicated to and specifically intended for the application of Frems™ and must be positioned according to set rules for each specific treatment and consolidated protocols for each application. Treatment consists in a cycle of daily sessions lasting approximately 30 minutes, performed either in a medical setting or at the patient’s home for a number of weeks. Consumable material The treatment is administered by positioning, in the area to be treated,...

APTIVA 4 THE MAIN UNIT • 4 simultaneously active channels • 4 cables, each of which has 8 leads for a total of 32 electrodes, allowing a complete, even bilateral, treatment • Electrode detachment alarm • Remote control for treatment management at a distance • User card • Mains power supply FREMS™ ELECTRODES The electrodes are an essential component for guaranteeing treatment efficacy. The contact impedance between electrode and patient is a potential critical point for energy transfer. The original Frems™ electrodes have been specifically designed to optimise this energy transfer. The...

Centro Studi FREMSLIFE Centro Studi Fremslife is a place dedicated to scientific exchange and training that provides a concrete support to our mission: TO GUARANTEE RESULTS TO IMPROVE QUALITY OF LIFE. With this initiative, Fremslife intends to provide a service that favours the scientific aspects of the technologies it manufactures, dedicating particular attention to the clinical evidence of the results obtained in the treatment of various conditions.

Directive 93/42/EEC and subsequent amendments. Fremslife is certified according to EN 13485:2012 The Aptiva™ system is also FDA510(k)-approved. Dichiarazione di approvazione del sistema qualità (Sistema completo di garanzia qualità) Visto l'esito delle verifiche condotte in conformità all'Allegato II, con l'esclusione del punto 4, della direttiva 93/42/CEE e s.m.i., si dichiara che la ditta: FREMSLIFE SRL 16149 GENOVA (GE) - VIA PIETRO CHIESA 9 (ITA) - Italy mantiene negli stabilimenti di: 40033 CASALECCHIO DI RENO (BO) - VIA MARGOTTI 6 (ITA) - Italy un sistema qualità che assicura la...